Dario Eklund is the founder of Santhera Pharmaceuticals. Backed by Highbridge Capital Management, LLC. Based in Pratteln, Switzerland.
Dario Eklund serves as the Chief Executive Officer of Santhera Pharmaceuticals. The company is dedicated to developing treatments for rare and severe diseases, with a current focus on vamorolone for Duchenne muscular dystrophy (DMD). Santhera Pharmaceuticals recently secured additional funding through a private placement of shares and an upsizing of an existing financing arrangement with Highbridge Capital Management.
Full founder directory · Investor directory · Company funding database · Fundraising library